[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596411":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":120,"collaborators":122,"id":137,"slug":138,"hasResults":139,"nctId":140,"briefTitle":141,"officialTitle":142,"acronym":143,"eligibilityCriteria":144,"healthyVolunteers":139,"sex":145,"minAge":146,"maxAge":10,"enrollmentInfo":147,"targetDuration":10,"studyType":150,"phases":10,"briefSummary":151,"conditions":152,"keywords":10,"overallStatus":15,"whyStopped":10,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":158,"completionDateStruct":160,"leadSponsor":162,"locationsCount":163},{"fullName":5,"class":6},"Invenio Imaging Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"ON-SITE Patients",null,"Participants must fulfill all of the following criteria in order to be eligible for the study:\n\n1. The patient or legal guardian is willing and able to understand, sign and date the Ethics committee-approved study specific Informed Consent Form.\n2. The patient is 22 years of age or older.\n3. The patient is scheduled for routinely indicated staging of the mediastinum (EBUS-TBNA) and planned peripheral lung biopsy procedure (peripheral-TBBx\u002FTBNA) with an intermediate to high pretest probability of lung cancer based on clinician suspicion.\n4. The patient can tolerate the clinical procedure as indicated.",[13,35,52,68,78,93,109],{"facility":14,"status":15,"city":16,"state":17,"zip":18,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"UC San Diego","RECRUITING","San Diego","California","92037","United States","US",{"type":22,"coordinates":23},"Point",[24,25],-117.16472,32.71571,{"lat":25,"lon":24},[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"George Z Cheng, MD","CONTACT","619-543-5840","gcheng@ucsd.edu",{"name":29,"role":34,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":19,"countryCode":20,"cosmosGeoPoint":41,"geoPoint":45,"contacts":46},"Mayo Clinic Jacksonville","NOT_YET_RECRUITING","Jacksonville","Florida","32224",{"type":22,"coordinates":42},[43,44],-81.65565,30.33218,{"lat":44,"lon":43},[47,51],{"name":48,"role":30,"phone":49,"phoneExt":10,"email":50},"Bryan Husta, MD","(904) 953-2861","Husta.Bryan@mayo.edu",{"name":48,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":53,"status":15,"city":54,"state":55,"zip":56,"country":19,"countryCode":20,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Corewell Health","Grand Rapids","Michigan","49503",{"type":22,"coordinates":58},[59,60],-85.66809,42.96336,{"lat":60,"lon":59},[63,67],{"name":64,"role":30,"phone":65,"phoneExt":10,"email":66},"Gustavo Cumbo-Nachelli, MD","616-821-8890","Gustavo.CumboNacheli@corewellhealth.org",{"name":64,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":69,"status":70,"city":71,"state":71,"zip":72,"country":19,"countryCode":20,"cosmosGeoPoint":73,"geoPoint":77,"contacts":10},"Memorial Sloan Kettering Cancer Center","SUSPENDED","New York","10065",{"type":22,"coordinates":74},[75,76],-74.00597,40.71427,{"lat":76,"lon":75},{"facility":79,"status":15,"city":80,"state":71,"zip":81,"country":19,"countryCode":20,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Montefiore Medical Center","The Bronx","10467",{"type":22,"coordinates":83},[84,85],-73.86641,40.84985,{"lat":85,"lon":84},[88,92],{"name":89,"role":30,"phone":90,"phoneExt":10,"email":91},"Daniel Da Costa, MD","718-920-6441","daniel.dacosta@nyulangone.org",{"name":89,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":94,"status":15,"city":95,"state":96,"zip":97,"country":19,"countryCode":20,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"UNC Medical Center","Chapel Hill","North Carolina","27514",{"type":22,"coordinates":99},[100,101],-79.05584,35.9132,{"lat":101,"lon":100},[104,108],{"name":105,"role":30,"phone":106,"phoneExt":10,"email":107},"Jason Akulian, MD","860-770-4835","akulian@email.unc.edu",{"name":105,"role":34,"phone":10,"phoneExt":10,"email":10},{"facility":110,"status":111,"city":112,"state":113,"zip":114,"country":19,"countryCode":20,"cosmosGeoPoint":115,"geoPoint":119,"contacts":10},"MD Anderson Cancer Center","ACTIVE_NOT_RECRUITING","Houston","Texas","77030",{"type":22,"coordinates":116},[117,118],-95.36327,29.76328,{"lat":118,"lon":117},{"type":121,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[123,125,127,129,131,133,136],{"name":69,"class":124},"OTHER",{"name":126,"class":124},"University of North Carolina, Chapel Hill",{"name":128,"class":124},"M.D. Anderson Cancer Center",{"name":130,"class":124},"Mayo Clinic",{"name":132,"class":124},"University of California, San Diego",{"name":134,"class":135},"Montefiore Medical Center-Moses-Weiler","UNKNOWN",{"name":53,"class":135},"100596411","a-multicenter-study-in-bronchoscopy-combining-stimulated-raman-histology-with-artificial-intelligence-for-rapid-lung-cancer-detection---the-on-site-study-100596411",false,"NCT07045103","A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study","A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection","ON-SITE","Inclusion Criteria:\n\n1. The patient or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.\n2. The patient is 22 years of age or older.\n3. The patient is scheduled for routinely indicated staging of the mediastinum (EBUS-TBNA) and planned peripheral lung biopsy procedure (peripheral TBBx\u002FTBNA) with an intermediate to high pretest probability of lung cancer based on clinician suspicion.\n4. The patient can tolerate the clinical procedure as indicated.\n\nExclusion Criteria:\n\n1. Patient is a prisoner.\n2. The participant, in the judgment of the Investigator, may be inappropriate for the intended study procedures","ALL","22 Years",{"count":148,"type":149},900,"ESTIMATED","OBSERVATIONAL","The ON-SITE study represents a prospective, observational study focused on the training\u002Ftuning and pivotal validation of deep learning algorithms that detect cell\u002Ftissue morphology suspicious for cancer in biopsies of peripheral lung nodules\u002Fmasses and mediastinal\u002Fhilar lymph nodes imaged with the NIO Laser Imaging System in the procedure room without requiring traditional sample processing.\n\nThe study includes four arms based on biopsy location and biopsy modality\u002Ftool:\n\n1. Transbronchial forceps biopsy of peripheral lung nodules\u002Fmasses (peripheral-TBBx)\n2. Transbronchial needle aspiration biopsy of peripheral lung nodules\u002Fmasses (peripheral TBNA)\n3. Transbronchial needle aspiration biopsy of mediastinal\u002Fhilar lymph nodes (EBUS-TBNA)\n4. Transbronchial cryo biopsy of peripheral lung nodules\u002Fmasses (peripheral-CBx)",[153],"Lung Biopsy","2025-06-20",{"date":156,"type":157},"2025-07-01","ACTUAL",{"date":159,"type":157},"2023-12-21",{"date":161,"type":149},"2026-05",{"name":5,"class":6},7]